Differences in prostate cancer detection between Canadian and Saudi populations

Differences in prostate cancer detection between Canadian and Saudi populations

Show other versions (1)

Few studies have addressed racial differences in prostate cancer (PCa) detection between Western and Arabian countries, although PCa has a significantly lower prevalence in Arabic populations compared to Western populations. Therefore, an explanation of this difference is lacking. Ser...

Full description

Bibliographic Details
Main Authors:	O.Z. Al-Abdin, D.M. Rabah, G. Badr, A. Kotb, A. Aprikian
Format:	Article
Language:	English
Published:	Associação Brasileira de Divulgação Científica 2013-06-01
Series:	Brazilian Journal of Medical and Biological Research
Subjects:	Prostate cancer Serum PSA PSA density Digital rectal examination
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2013000600539&lng=en&tlng=en

Similar Items

Differences in prostate cancer detection between Canadian and Saudi populations
by: O.Z. Al-Abdin, et al.
Published: (2013-01-01)

Do all patients with suspicious prostate cancer need Multiparametric Magnetic Resonance Imaging before prostate biopsy?
by: Sara Teixeira Anacleto, et al.
Published: (2022-03-01)

PSA levels of 4.0 - 10 ng/ml and negative digital rectal examination: antibiotic therapy versus immediate prostate biopsy
by: Avraham Shtricker, et al.
Published: (2009-10-01)

Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml
by: Tsung-Hsin Chang, et al.
Published: (2020-10-01)

Evaluation of the clinical, biological and sonographic criteria, single or combined, to the prostate carcinoma diagnosis
by: Juan Carlos Mantilla Súarez, et al.
Published: (2006-08-01)

Diagnostic value of free-to-total PSA proportion and PSA density in prostate cancer detection for prostate volumes >= 100 cc
by: Murat Zor, et al.
Published: (2018-12-01)

Prostate – Specific Antigen (Psa) as a Screening Tool for Benign Prostate Hyperplasia (Bph) and Prostate Cancer (Pca) in Sulaimani Province
by: Sirwan M. Muhammad, et al.
Published: (2013-09-01)

Relation between Serum Level of Total PSA and Free PSA/Total PSA Ratio with Grade of Prostate Cancer
by: Mohammad Yazdani, et al.
Published: (2013-10-01)

Clinical-morphological characteristics of pathological changes in the prostate
by: Ilić Aleksandra, et al.
Published: (2019-01-01)

The Accuracy of Increased Blood Concentration of Prostate-Specific Antigen to Prostate Malignancy
by: Daniel Mahendra Krisna, et al.
Published: (2018-04-01)

ADENOKARSINOMA PROSTAT: PENILAIAN PROGNOSTIK DAN DERAJAT HISTOPATOLOGI
by: Anandia Putriyuni, et al.
Published: (2014-09-01)

The effect on the sensitivities of PSA and PSA-age volume score of IPSS and nocturia in predicting positive prostate biopsy findings
by: O. Üçer, et al.
Published: (2017-06-01)

A new predictor is comparable to the updated nomogram in predicting the intermediate- and high-risk prostate cancer but outperforms nomogram in reducing the overtreatment for the low-risk Pca
by: Wang H, et al.
Published: (2019-04-01)

Clinical diagnosis of prostate cancer using digital rectal examination and prostate-specific antigen tests: a systematic review and meta-analysis of sensitivity and specificity
by: Nelson C. Okpua, et al.
Published: (2021-02-01)

Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage?
by: Strittmatter F, et al.
Published: (2011-10-01)

Molecular Detection of Prostate Specific Antigen in Patients with Prostate Cancer or Benign Prostate Hyperplasia the First Investigation from Iran
by: L Andonian, et al.
Published: (2005-08-01)

Molecular Detection of Prostate Specific Antigen in Patients with Prostate Cancer or Benign Prostate Hyperplasia the First Investigation from Iran
by: L Andonian, et al.
Published: (2005-09-01)

Prostate-specific antigen kinetics and metastasis-free survival in patients treated with external beam radiotherapy combined with high-dose-rate brachytherapy boost and androgen deprivation therapy for localized prostate cancer
by: Marcin Miszczyk, et al.
Published: (2022-02-01)

Kinetics of Prostate-Specific Antigen after Carbon Ion Radiotherapy for Prostate Cancer
by: Narisa Dewi Maulany Darwis, et al.
Published: (2020-03-01)

Evaluation of the Cure about the Prostate Cancer Patients, Taking Radiothraphy According To the Result of the Prosecution Prostate Specific Antigen
by: Feryal Karaca, et al.
Published: (2018-10-01)

A new approach to prostate cancer screening
by: Filella Xavier, et al.
Published: (2023-08-01)

Prostate-Specific Antigen 5 Years following Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: An Ablative Procedure?
by: Shaan Kataria, et al.
Published: (2017-07-01)

Evaluation of prostate-specific antigen testing: An empirical survey of laboratories in Nigerian tertiary care centers
by: Ijeoma A Meka, et al.
Published: (2022-01-01)

Prognostic significance of Prostate-Specific Antigen (PSA) rate of change in patients with advanced prostate cancer
by: A E Aghaji, et al.
Published: (2005-01-01)

Prostate Specific Antigen. Current clinical application and future prospects
by: Katerina Duskova, et al.
Published: (2015-03-01)

Association between preoperative prostate-specific antigen levels and mortality in high- and intermediate-grade prostate cancer patients who received radical prostatectomy: Findings from the SEER database
by: Joshua Ikuemonisan, et al.
Published: (2021-06-01)

Optimized Identification of High-Grade Prostate Cancer by Combining Different PSA Molecular Forms and PSA Density in a Deep Learning Model
by: Francesco Gentile, et al.
Published: (2021-02-01)

Initial Brazilian experience in the treatment of localized prostate cancer using a new generation cryotechnology: feasibility study
by: Fernando J. Kim, et al.
Published: (2012-10-01)

PROSTATE CANCER MANAGEMENT IN MOEWARDI HOSPITAL SURAKARTA FROM JANUARY 2000 – DECEMBER 2006
by: Endi Prilansa Mahadi, et al.
Published: (2014-09-01)

The knowledge and attitude towards prostate cancer and screening practices among males in Saudi Arabia
by: Abdulrahman Musaad Alothman, et al.
Published: (2022-01-01)

Pulmonary recurrence from prostate cancer and biochemical remission after metastasis directed therapy. A case report
by: Riccardo Boschian, et al.
Published: (2018-03-01)

The clinical impact of WHO standardization of PSA assays
by: Blanchet Jean-Sébastien, et al.
Published: (2008-01-01)

Effect of urinary retention on the levels of prostate specific antigen (PSA) and prostatic acid phosphatase (PAP) in prostatic disease
by: R Chawla, et al.
Published: (2003-01-01)

Diagnostic accuracy of MRI-based PSA density for detection of prostate cancer among the Thai population
by: Chalida Aphinives, et al.
Published: (2023-01-01)

Early prostate specific antigen decline and its velocity are independent predictive factors for outcomes of mCRPC patients treated with abiraterone acetate
by: Jiang-Yi Wang, et al.
Published: (2022-01-01)

Prostate Specific Antigen Levels Among Men With Prostate Cancer in Ramadi City
by: Jalil Ibrahim Salih, et al.
Published: (2013-08-01)

Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy boost as post-external beam radiotherapy versus conventionally fractionated external beam radiotherapy for localized prostate cancer
by: Jeong Hoon Phak, et al.
Published: (2016-03-01)

Determining the degree of alignment of prostate carcinoma in a rectal biopsy with radical prostatectomy in patients with prostate carcinoma
by: Kamaleddin Hassanzadeh, et al.
Published: (2021-02-01)

Comparative analysis of resected prostate weight in diabetic and non-diabetic benign prostatic hyperplasia patients
by: Emadouddin Moudi, et al.
Published: (2017-02-01)

Comparison of changes in serum prostate specific antigen in prostate cancer patients treated either with flutamide or stilboestrol monotherapy
by: O F Otobo, et al.
Published: (2020-01-01)